cdh3 has 9 expression phenotype(s)
Images Sources Experiment + Assay Phenotypes Human Diseases
Fig S3 D

Zhang Z et al. (2016) 		Xla Wt + cdh3 MO

NF19 (immunohistochemistry)
Expression Phenotype
decreased amount ctnnb1.L expression in foregut
fig.S2.a^1, a^2

Ninomiya H et al. (2012) 		Xla Wt + cdh3

NF10.5 (immunohistochemistry)
Expression Phenotype
increased amount cdh3.L expression in ectodermal cell
increased amount ctnnb1.L expression in ectodermal cell
fig.4.e, e^1, e^2

Ninomiya H et al. (2012) 		Xla Wt + cdh3

NF10.5 (immunohistochemistry)
Expression Phenotype
increased amount ctnnb1.L expression in ectodermal cell
fig.S2.b^1, b^2

Ninomiya H et al. (2012) 		Xla Wt + cdh3 MO

NF10.5 (immunohistochemistry)
Expression Phenotype
decreased amount cdh3.L expression in epidermal cell
fig.S2.g^1, g^2

Ninomiya H et al. (2012) 		Xla Wt + cdh3 MO

NF10.5 (immunohistochemistry)
Expression Phenotype
decreased amount ctnnb1.L expression in epidermal cell
fig.1.l^1, l^2

Ninomiya H et al. (2012) 		Xla Wt + cdh3 MO

NF12.5 (immunohistochemistry)
Expression Phenotype
mislocalised ctnnb1.L expression in mesoderm
fig.1.b

Ninomiya H et al. (2012) 		Xla Wt + cdh3 MO

NF12.5 (in situ hybridization)
Anatomical Phenotype
abnormal gastrulation
Expression Phenotype
mislocalised gsc.L expression in mesoderm
fig.1.d

Ninomiya H et al. (2012) 		Xla Wt + cdh3 MO

NF12.5 (in situ hybridization)
Anatomical Phenotype
abnormal axial mesoderm morphology
abnormal gastrulation
Expression Phenotype
mislocalised tbxt.S expression in axial mesoderm
fig.S2.d^1, d^2

Ninomiya H et al. (2012) 		Xla Wt + cdh3del_2240-2699

NF10.5 (immunohistochemistry)
Expression Phenotype
increased amount cdh3.L expression in ectodermal cell
increased amount ctnnb1.L expression in ectodermal cell
mislocalised ctnnb1.L expression in ectodermal cell